[Form 4] Alignment Healthcare, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Alignment Healthcare (ALHC) insider Form 4: The filing shows Hyong (Ken) Kim, identified as Chief Medical Officer and an officer of the company, reported an open-market sale of 24,800 shares of the issuer's common stock on 08/22/2025 at a reported price of $16 per share. After the sale, Mr. Kim beneficially owned 447,367 shares, held directly. The Form 4 notes the transaction was made pursuant to a Rule 10b5-1 trading plan adopted on 03/14/2025. The form is signed by Christopher J. Joyce as attorney-in-fact on 08/22/2025.

Positive

• Transaction executed under a Rule 10b5-1 plan, adopted 03/14/2025, which indicates the sale was pre-arranged
• Reporting person retains a significant direct holding of 447,367 shares after the sale

Negative

• Insider sale of 24,800 shares on 08/22/2025 at $16 per share, representing insider liquidity

Insights

Securities Analyst

TL;DR: Routine insider sale under a pre-established 10b5-1 trading plan; informational but not necessarily material.

The reported sale of 24,800 shares at $16 was executed pursuant to a Rule 10b5-1 plan adopted 03/14/2025, indicating the disposition was prearranged. The filing shows the reporting person remains a substantial direct holder with 447,367 shares after the transaction. For investors, this filing documents insider liquidity but provides no new operational or financial disclosures about Alignment Healthcare.

Corporate Governance Expert

TL;DR: Disclosure aligns with standard governance practices for planned insider trades.

The Form 4 identifies the seller as the Chief Medical Officer and records a sale executed under a 10b5-1 plan, which is a common governance mechanism to mitigate allegations of trading on material nonpublic information. The filing is complete for the reported transaction and includes attorney-in-fact signature; it does not disclose any other governance events or leadership changes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim Hyong

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		S(1)		24,800	D	$16	447,367	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Date of Rule 10b5-1 plan adoption: 03/14/2025

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Hyong (Ken) Kim	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for ALHC filed by Hyong (Ken) Kim report?

The Form 4 reports a sale of 24,800 shares of Alignment Healthcare common stock on 08/22/2025 at $16 per share and shows 447,367 shares beneficially owned after the sale.

Was the insider sale by ALHC's Chief Medical Officer part of a 10b5-1 plan?

Yes. The Form 4 states the transaction was made pursuant to a Rule 10b5-1 plan adopted on 03/14/2025.

How many shares did the reporting person own after the reported transaction?

447,367 shares were beneficially owned following the reported sale.

Who signed the Form 4 on behalf of the reporting person?

Christopher J. Joyce, as Attorney-in-Fact, signed the Form 4 on 08/22/2025 for Hyong (Ken) Kim.

What is the reporting person's role at Alignment Healthcare (ALHC)?

Listed role: Chief Medical Officer and an officer of the issuer.